Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

The results of the ONWARDS 2 trial of insulin icodec showed that it was as effective as daily dosing with Novo Nordisk's Tresiba (insulin degludec) once per day at controlling blood glucose ...

Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Its portfolio includes insulin analogs, GLP-1 receptor agonists, and oral antidiabetic drugs like Rybelsus, Ozempic, and Tresiba. Novo Nordisk A/S (NYSE:NVO) delivered exceptional financial ...

Dosage will vary depending on the individual. Tresiba (insulin degludec injection) was approved in 2015. It is a long-acting injectable insulin that is used to improve glycemic control in adults ...

Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...

Insulin resistance in the brain is associated with obesity, type 2 diabetes, and cognitive dysfunction. Insulin normally regulates appetite and metabolism through brain signaling, but resistance ...

High insulin sensitivity allows the body’s cells to use blood glucose more effectively, reducing blood sugar. Some lifestyle, self-care, and dietary changes may help increase insulin sensitivity.